Department of Graduate and Scientific Research, Zunyi Medical University Zhuhai Campus, Zhuhai 519041, China; Department of Otolaryngology, Longgang E.N.T Hospital & Shenzhen Key Laboratory of E.N.T, Institute of E.N.T, Shenzhen 518172, China.
Department of Otolaryngology, Longgang E.N.T Hospital & Shenzhen Key Laboratory of E.N.T, Institute of E.N.T, Shenzhen 518172, China; Department of Otolaryngology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, China; Department of Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangzhou, 510000, China.
Neurobiol Dis. 2023 Oct 15;187:106320. doi: 10.1016/j.nbd.2023.106320. Epub 2023 Oct 7.
Age-related hearing loss (ARHL) is a prevalent condition affecting millions of individuals globally. This study investigated the role of the cell survival regulator Bcl2 in ARHL through in vitro and in vivo experiments and metabolomics analysis. The results showed that the lack of Bcl2 in the auditory cortex affects lipid metabolism, resulting in reduced synaptic function and neurodegeneration. Immunohistochemical analysis demonstrated enrichment of Bcl2 in specific areas of the auditory cortex, including the secondary auditory cortex, dorsal and ventral areas, and primary somatosensory cortex. In ARHL rats, a significant decrease in Bcl2 expression was observed in these areas. RNAseq analysis showed that the downregulation of Bcl2 altered lipid metabolism pathways within the auditory pathway, which was further confirmed by metabolomics analysis. These results suggest that Bcl2 plays a crucial role in regulating lipid metabolism, synaptic function, and neurodegeneration in ARHL; thereby, it could be a potential therapeutic target. We also revealed that Bcl2 probably has a close connection with lipid peroxidation and reactive oxygen species (ROS) production occurring in cochlear hair cells and cortical neurons in ARHL. The study also identified changes in hair cells, spiral ganglion cells, and nerve fiber density as consequences of Bcl2 deficiency, which could potentially contribute to the inner ear nerve blockage and subsequent hearing loss. Therefore, targeting Bcl2 may be a promising potential therapeutic intervention for ARHL. These findings provide valuable insights into the molecular mechanisms underlying ARHL and may pave the way for novel treatment approaches for this prevalent age-related disorder.
年龄相关性听力损失(ARHL)是一种普遍存在的病症,影响着全球数以百万计的人群。本研究通过体外和体内实验以及代谢组学分析,探讨了细胞存活调节剂 Bcl2 在 ARHL 中的作用。结果表明,听觉皮层中缺乏 Bcl2 会影响脂质代谢,导致突触功能下降和神经退行性变。免疫组织化学分析表明,Bcl2 在听觉皮层的特定区域富集,包括次级听觉皮层、背侧和腹侧区域以及初级体感皮层。在 ARHL 大鼠中,这些区域的 Bcl2 表达显著下降。RNAseq 分析显示,Bcl2 的下调改变了听觉通路中的脂质代谢途径,代谢组学分析进一步证实了这一点。这些结果表明,Bcl2 在调节 ARHL 中的脂质代谢、突触功能和神经退行性变中起着至关重要的作用;因此,它可能成为一个有潜力的治疗靶点。我们还揭示了 Bcl2 可能与 ARHL 中耳蜗毛细胞和皮质神经元中发生的脂质过氧化和活性氧(ROS)产生密切相关。研究还发现,Bcl2 缺乏会导致毛细胞、螺旋神经节细胞和神经纤维密度发生变化,这可能导致内耳神经阻塞和随后的听力损失。因此,靶向 Bcl2 可能是 ARHL 一种有前途的潜在治疗干预措施。这些发现为 ARHL 的分子机制提供了有价值的见解,并可能为这种普遍的与年龄相关的疾病开辟新的治疗方法。